Summary
An Iranian study aimed to evaluate the effects of selenium supplementation on the function of the metabolism, including glucose balance, inflammation levels, and oxidative stress in patients with diabetes type 2 and coronary heart disease. 60 patients were divided into two groups. For 8 weeks, the first group (30 patients) received 200 µg of selenium per day and the second group (30 patients) received a placebo. Fasting blood samples were taken at the start of the study and after 8 weeks of intervention. After 8 weeks, selenium supplementation resulted in a significantly improved glucose metabolism and a significant reduction of inflammation markers compared to patients in the placebo group. More details can be found in the study.
References
Farrokhian et al.